In our study populations, the ESR1’s transcript levels were abnormally increased in 40% of IBC, 64% of DCIS, and 0% of noncancer, based on the up-1 cutoff separating class 0 from 1 and higher. Here, ESR1 is linked to ductal breast carcinoma in situ.